HEATR1 negatively regulates Akt to increase the cancer cells’ sensitivity to chemotherapy, making it a possible predictive and prognostic biomarker for treatment responsiveness and the prognosis of patients with pancreatic cancer, according to Liu et al. (Liu et al., 2016). The gene discussed is AKT1; the disease is familial pancreatic carcinoma.